Xtant Medical Holdings Stock EBITDA

XTNT Stock

USD 0.40 0.01 2.44%

Xtant Medical Holdings fundamentals help investors to digest information that contributes to Xtant Medical's financial success or failures. It also enables traders to predict the movement of Xtant Stock. The fundamental analysis module provides a way to measure Xtant Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xtant Medical stock.

		Last Reported	Projected for Next Year
	EBITDA	5.1 M	5.3 M

EBITDA is likely to gain to about 5.3 M in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Xtant Medical Holdings Company EBITDA Analysis

Xtant Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Xtant Medical EBITDA

5.07 M

Most of Xtant Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xtant Medical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Xtant EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Xtant Medical is extremely important. It helps to project a fair market value of Xtant Stock properly, considering its historical fundamentals such as EBITDA. Since Xtant Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Xtant Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Xtant Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Current Deferred Revenue	Short Term Debt	Intangible Assets	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Net Tangible Assets	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital
Total Assets		0.0	0.76	-0.16	0.92	0.76	0.82	0.76	0.83	0.15	0.91	-0.42	0.75	0.92	0.9	-0.52	0.61	0.08	0.02	0.2	0.11
Total Stockholder Equity	0.0		-0.62	-0.24	-0.17	0.31	-0.52	0.29	-0.22	0.39	-0.01	-0.03	-0.64	-0.17	-0.26	0.81	-0.43	-0.69	0.52	0.03	0.5
Net Debt	0.76	-0.62		0.04	0.81	0.44	0.98	0.34	0.77	-0.11	0.73	-0.25	0.99	0.84	0.88	-0.92	0.74	0.5	-0.36	0.12	-0.28
Retained Earnings	-0.16	-0.24	0.04		-0.05	-0.46	-0.05	-0.65	-0.35	-0.39	0.18	0.52	0.02	-0.04	0.11	-0.33	0.04	0.83	-0.88	0.79	-0.66
Accounts Payable	0.92	-0.17	0.81	-0.05		0.72	0.87	0.64	0.77	-0.03	0.82	-0.44	0.8	0.88	0.87	-0.62	0.62	0.26	-0.15	0.3	0.02
Net Receivables	0.76	0.31	0.44	-0.46	0.72		0.56	0.77	0.61	0.18	0.6	-0.5	0.41	0.68	0.55	-0.09	0.25	-0.3	0.29	-0.01	0.45
Total Liab	0.82	-0.52	0.98	-0.05	0.87	0.56		0.44	0.83	-0.12	0.76	-0.36	0.98	0.88	0.9	-0.86	0.75	0.41	-0.3	0.11	-0.17
Total Current Assets	0.76	0.29	0.34	-0.65	0.64	0.77	0.44		0.67	0.29	0.46	-0.63	0.36	0.57	0.44	-0.02	0.26	-0.46	0.62	-0.19	0.62
Current Deferred Revenue	0.83	-0.22	0.77	-0.35	0.77	0.61	0.83	0.67		0.11	0.62	-0.46	0.78	0.72	0.84	-0.58	0.82	0.03	0.1	-0.01	0.07
Short Term Debt	0.15	0.39	-0.11	-0.39	-0.03	0.18	-0.12	0.29	0.11		0.08	-0.06	-0.16	0.09	0.03	0.27	-0.23	-0.53	0.49	-0.35	-0.03
Intangible Assets	0.91	-0.01	0.73	0.18	0.82	0.6	0.76	0.46	0.62	0.08		-0.16	0.71	0.89	0.9	-0.58	0.56	0.3	-0.28	0.39	-0.15
Common Stock	-0.42	-0.03	-0.25	0.52	-0.44	-0.5	-0.36	-0.63	-0.46	-0.06	-0.16		-0.27	-0.32	-0.19	0.05	-0.17	0.26	-0.29	0.28	-0.22
Long Term Debt	0.75	-0.64	0.99	0.02	0.8	0.41	0.98	0.36	0.78	-0.16	0.71	-0.27		0.83	0.87	-0.92	0.76	0.49	-0.34	0.1	-0.23
Property Plant Equipment	0.92	-0.17	0.84	-0.04	0.88	0.68	0.88	0.57	0.72	0.09	0.89	-0.32	0.83		0.9	-0.65	0.5	0.24	-0.18	0.18	-0.03
Good Will	0.9	-0.26	0.88	0.11	0.87	0.55	0.9	0.44	0.84	0.03	0.9	-0.19	0.87	0.9		-0.76	0.78	0.38	-0.31	0.35	-0.21
Net Tangible Assets	-0.52	0.81	-0.92	-0.33	-0.62	-0.09	-0.86	-0.02	-0.58	0.27	-0.58	0.05	-0.92	-0.65	-0.76		-0.72	-0.76	0.61	-0.25	0.51
Short Long Term Debt	0.61	-0.43	0.74	0.04	0.62	0.25	0.75	0.26	0.82	-0.23	0.56	-0.17	0.76	0.5	0.78	-0.72		0.37	-0.26	0.2	-0.24
Long Term Debt Total	0.08	-0.69	0.5	0.83	0.26	-0.3	0.41	-0.46	0.03	-0.53	0.3	0.26	0.49	0.24	0.38	-0.76	0.37		-0.93	0.65	-0.67
Capital Surpluse	0.02	0.52	-0.36	-0.88	-0.15	0.29	-0.3	0.62	0.1	0.49	-0.28	-0.29	-0.34	-0.18	-0.31	0.61	-0.26	-0.93		-0.64	0.77
Net Invested Capital	0.2	0.03	0.12	0.79	0.3	-0.01	0.11	-0.19	-0.01	-0.35	0.39	0.28	0.1	0.18	0.35	-0.25	0.2	0.65	-0.64		-0.28
Net Working Capital	0.11	0.5	-0.28	-0.66	0.02	0.45	-0.17	0.62	0.07	-0.03	-0.15	-0.22	-0.23	-0.03	-0.21	0.51	-0.24	-0.67	0.77	-0.28

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Xtant Medical

Ebitda Over Time

Xtant Ebitda

Ebitda

5.33 Million

At this time, Xtant Medical's EBITDA is comparatively stable compared to the past year.

According to the company disclosure, Xtant Medical Holdings reported earnings before interest,tax, depreciation and amortization of 5.07 M. This is 99.42% lower than that of the Health Care Equipment & Supplies sector and 99.21% lower than that of the Health Care industry. The ebitda for all United States stocks is 99.87% higher than that of the company.

Xtant EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xtant Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xtant Medical could also be used in its relative valuation, which is a method of valuing Xtant Medical by comparing valuation metrics of similar companies.

Xtant Medical is currently under evaluation in ebitda category among its peers.

Xtant Medical Current Valuation Drivers

We derive many important indicators used in calculating different scores of Xtant Medical from analyzing Xtant Medical's financial statements. These drivers represent accounts that assess Xtant Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Xtant Medical's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	21.1M	34.1M	47.9M	62.1M	134.6M	141.3M
Enterprise Value	94.4M	50.3M	46.5M	58.9M	152.4M	107.5M

Xtant Fundamentals

	Return On Equity	-0.0877
	Return On Asset	-0.11
	Profit Margin	(0.03) %
	Operating Margin	(0.1) %
	Current Valuation	84.96 M
	Shares Outstanding	139.01 M
	Shares Owned By Insiders	7.83 %
	Shares Owned By Institutions	65.12 %
	Number Of Shares Shorted	197.47 K
	Price To Earning	(0.41) X
	Price To Book	1.22 X
	Price To Sales	0.50 X
	Revenue	91.3 M
	Gross Profit	32.14 M
	EBITDA	5.07 M
	Net Income	660 K
	Cash And Equivalents	16.5 M
	Cash Per Share	0.19 X
	Total Debt	23.56 M
	Debt To Equity	0.60 %
	Current Ratio	3.57 X
	Book Value Per Share	0.39 X
	Cash Flow From Operations	(9.52 M)
	Short Ratio	6.92 X
	Earnings Per Share	(0.13) X
	Price To Earnings To Growth	(0.03) X
	Target Price	2.25
	Number Of Employees	207
	Beta	0.39
	Market Capitalization	55.6 M
	Total Asset	92.61 M
	Retained Earnings	(243.01 M)
	Working Capital	41.88 M
	Current Asset	45.04 M
	Current Liabilities	21.47 M
	Net Asset	92.61 M

About Xtant Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Xtant Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xtant Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xtant Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC